| Mrs Antoinette Marie Oakes, CRNA | |
|
100 Grand St, New Britain, CT 06052-2016 | |
| (860) 224-5266 | |
| Not Available |
| Full Name | Mrs Antoinette Marie Oakes |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 25 Years |
| Location | 100 Grand St, New Britain, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386689883 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 002382 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Connecticut Gi Pc | 9830110758 | 185 |
News Archive
A cell-to-cell signaling network that serves as a developmental timer could provide a framework for better understanding the mechanisms underlying human heart valve disease, say University of Oregon scientists.
The lack of a breast cancer risk prediction model tailored to Black women represents a critical gap, given that U.S. Black women, on average, are more likely to have breast cancer at earlier ages and with a worse prognosis than White women.
A new investigational drug designed to stop cancer cells from reproducing may offer hope for patients with advanced solid tumor cancers. Clinical trials of TKM-PLK1 for qualified patients are now open at the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
Early-stage non-small cell lung cancer (NSCLC) patients with squamous cell carcinoma (SqCC) have a significantly higher rate of local failure after stereotactic body radiation therapy (SBRT) than other NSCLC histological subtypes.
› Verified 5 days ago
| Entity Name | North American Partners In Anesthesia Connecticut Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316994775 PECOS PAC ID: 6709877939 Enrollment ID: O20040519000120 |
News Archive
A cell-to-cell signaling network that serves as a developmental timer could provide a framework for better understanding the mechanisms underlying human heart valve disease, say University of Oregon scientists.
The lack of a breast cancer risk prediction model tailored to Black women represents a critical gap, given that U.S. Black women, on average, are more likely to have breast cancer at earlier ages and with a worse prognosis than White women.
A new investigational drug designed to stop cancer cells from reproducing may offer hope for patients with advanced solid tumor cancers. Clinical trials of TKM-PLK1 for qualified patients are now open at the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
Early-stage non-small cell lung cancer (NSCLC) patients with squamous cell carcinoma (SqCC) have a significantly higher rate of local failure after stereotactic body radiation therapy (SBRT) than other NSCLC histological subtypes.
› Verified 5 days ago
| Entity Name | Connecticut Gi Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023124625 PECOS PAC ID: 9830110758 Enrollment ID: O20070112000011 |
News Archive
A cell-to-cell signaling network that serves as a developmental timer could provide a framework for better understanding the mechanisms underlying human heart valve disease, say University of Oregon scientists.
The lack of a breast cancer risk prediction model tailored to Black women represents a critical gap, given that U.S. Black women, on average, are more likely to have breast cancer at earlier ages and with a worse prognosis than White women.
A new investigational drug designed to stop cancer cells from reproducing may offer hope for patients with advanced solid tumor cancers. Clinical trials of TKM-PLK1 for qualified patients are now open at the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
Early-stage non-small cell lung cancer (NSCLC) patients with squamous cell carcinoma (SqCC) have a significantly higher rate of local failure after stereotactic body radiation therapy (SBRT) than other NSCLC histological subtypes.
› Verified 5 days ago
| Entity Name | Endoscopy Center Of Connecticut, Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1386757854 PECOS PAC ID: 0143226712 Enrollment ID: O20070117000018 |
News Archive
A cell-to-cell signaling network that serves as a developmental timer could provide a framework for better understanding the mechanisms underlying human heart valve disease, say University of Oregon scientists.
The lack of a breast cancer risk prediction model tailored to Black women represents a critical gap, given that U.S. Black women, on average, are more likely to have breast cancer at earlier ages and with a worse prognosis than White women.
A new investigational drug designed to stop cancer cells from reproducing may offer hope for patients with advanced solid tumor cancers. Clinical trials of TKM-PLK1 for qualified patients are now open at the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
Early-stage non-small cell lung cancer (NSCLC) patients with squamous cell carcinoma (SqCC) have a significantly higher rate of local failure after stereotactic body radiation therapy (SBRT) than other NSCLC histological subtypes.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Antoinette Marie Oakes, CRNA 68 South Service Road, Suite 350, Melville, NY 11747-4049 Ph: (516) 945-3000 | Mrs Antoinette Marie Oakes, CRNA 100 Grand St, New Britain, CT 06052-2016 Ph: (860) 224-5266 |
News Archive
A cell-to-cell signaling network that serves as a developmental timer could provide a framework for better understanding the mechanisms underlying human heart valve disease, say University of Oregon scientists.
The lack of a breast cancer risk prediction model tailored to Black women represents a critical gap, given that U.S. Black women, on average, are more likely to have breast cancer at earlier ages and with a worse prognosis than White women.
A new investigational drug designed to stop cancer cells from reproducing may offer hope for patients with advanced solid tumor cancers. Clinical trials of TKM-PLK1 for qualified patients are now open at the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
Early-stage non-small cell lung cancer (NSCLC) patients with squamous cell carcinoma (SqCC) have a significantly higher rate of local failure after stereotactic body radiation therapy (SBRT) than other NSCLC histological subtypes.
› Verified 5 days ago
Ms. Kristine M Glenney, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 100 Grand St, New Britain, CT 06052 Phone: 860-224-5011 | |
Jacqueline Futia, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 100 Grand St, New Britain, CT 06052 Phone: 860-224-5266 | |
Christina Koscuk, RN Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 100 Grand St, New Britain, CT 06052 Phone: 860-224-5011 | |
Mr. Christopher Collins Weldon, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 100 Grand St, New Britain, CT 06052 Phone: 860-224-5266 Fax: 860-826-4992 | |
Mrs. Patricia Pearsall, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 100 Grand St, New Britain, CT 06052 Phone: 860-224-5266 | |
Jason Andrews, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 100 Grand St, New Britain, CT 06052 Phone: 860-224-5266 | |
Mrs. Elizabeth Parker, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 100 Grand Street, New Britain, CT 06050 Phone: 860-563-0700 |